ST2 is an IL-1 receptor family member with transmembrane (ST2L) and soluble (sST2) isoforms. sST2 is a mechanically induced cardiomyocyte protein, and serum sST2 levels predict outcome in patients with acute myocardial infarction or chronic heart failure. Recently, IL-33 was identified as a functional ligand of ST2L, allowing exploration of the role of ST2 in myocardium. We found that IL-33 was a biomechanically induced protein predominantly synthesized by cardiac fibroblasts. IL-33 markedly antagonized angiotensin II– and phenylephrine-induced cardiomyocyte hypertrophy. Although IL-33 activated NF-κB, it inhibited angiotensin II– and phenylephrine-induced phosphorylation of inhibitor of NF-κBα (IκBα) and NF-κB nuclear binding activity. sST2 blocked antihypertrophic effects of IL-33, indicating that sST2 functions in myocardium as a soluble decoy receptor. Following pressure overload by transverse aortic constriction (TAC), ST2–/– mice had more left ventricular hypertrophy, more chamber dilation, reduced fractional shortening, more fibrosis, and impaired survival compared with WT littermates. Furthermore, recombinant IL-33 treatment reduced hypertrophy and fibrosis and improved survival after TAC in WT mice, but not in ST2–/– littermates. Thus, IL-33/ST2 signaling is a mechanically activated, cardioprotective fibroblast-cardiomyocyte paracrine system, which we believe to be novel. IL-33 may have therapeutic potential for beneficially regulating the myocardial response to overload.
Shoji Sanada, Daihiko Hakuno, Luke J. Higgins, Eric R. Schreiter, Andrew N.J. McKenzie, Richard T. Lee
Title and authors | Publication | Year |
---|---|---|
Graft IL-33 regulates infiltrating macrophages to protect against chronic rejection
Tengfang Li, Zhongqiang Zhang, Joseph Guido Bartolacci, Gaelen K. Dwyer, Quan Liu, Lisa Mathews, Murugesan Velayutham, Anna Roessing, Yoojin C. Lee, Helong Dai, Sruti Shiva, Martin H. Oberbarnscheidt, Jenna L. Dziki, Steven J. Mullett, Stacy G. Wendell, James D. Wilkinson, .Steven A Webber, Michelle A. Wood-Trageser, Simon C. Watkins, Anthony J. Demetris, George S. Hussey, Stephen F. Badylak, Heth R. Turnquist |
Journal of Clinical Investigation | 2020 |
Angiotensin Converting Enzyme Inhibitors (ACEIs) Decrease the Progression of Cardiac Fibrosis in Rheumatic Heart Disease Through the Inhibition of IL-33/sST2
AM Ambari, B Setianto, A Santoso, B Radi, B Dwiputra, E Susilowati, F Tulrahmi, PA Doevendans, MJ Cramer |
Frontiers in Cardiovascular Medicine | 2020 |
Mesenchymal-endothelial transition-derived cells as a potential new regulatory target for cardiac hypertrophy
W Dong, R Li, H Yang, Y Lu, L Zhou, L Sun, D Wang, J Duan |
Scientific Reports | 2020 |
Single-cell analysis of murine fibroblasts identifies neonatal to adult switching that regulates cardiomyocyte maturation
Y Wang, F Yao, L Wang, Z Li, Z Ren, D Li, M Zhang, L Han, S Wang, B Zhou, L Wang |
Nature Communications | 2020 |
Sterile inflammation in thoracic transplantation
CC Frye, AI Bery, D Kreisel, HS Kulkarni |
Cellular and Molecular Life Sciences | 2020 |
Nuclear Alarmin Cytokines in Inflammation
L Jiang, Y Shao, Y Tian, C Ouyang, X Wang, X Rao |
Journal of Immunology Research | 2020 |
Cardiac fibrosis
NG Frangogiannis |
Cardiovascular Research | 2020 |
Right ventricular phenotype, function, and failure: a journey from evolution to clinics
YJ Taverne, A Sadeghi, B Bartelds, AJ Bogers, D Merkus |
Heart Failure Reviews | 2020 |
IL33 and Mast Cells—The Key Regulators of Immune Responses in Gastrointestinal Cancers?
MF Eissmann, M Buchert, M Ernst |
Frontiers in immunology | 2020 |
The Contradictory Role of Interleukin-33 in Immune Cells and Tumor Immunity X Zhang, W Chen, P Zeng, J Xu, H Diao |
Cancer management and research | 2020 |
Interleukin-36 Cytokine/Receptor Signaling: A New Target for Tissue Fibrosis
E Melton, H Qiu |
International journal of molecular sciences | 2020 |
Crosstalk between cardiomyocytes and noncardiomyocytes is essential to prevent cardiomyocyte apoptosis induced by proteasome inhibition
F Guo, CC Zhang, , T Li, CH Fang, |
Cell Death and Disease | 2020 |
Soluble St2 Induces Cardiac Fibroblast Activation and Collagen Synthesis via Neuropilin-1
L Matilla, V Arrieta, E Jover, A Garcia-Peña, E Martinez-Martinez, R Sadaba, V Alvarez, A Navarro, A Fernandez-Celis, A Gainza, E Santamaria, J Fernandez-Irigoyen, P Rossignol, F Zannad, N Lopez-Andres |
Cells | 2020 |
The pro-inflammatory marker soluble suppression of tumorigenicity-2 (ST2) is reduced especially in diabetic morbidly obese patients undergoing bariatric surgery
S Demyanets, C Kaun, A Kaider, W Speidl, M Prager, S Oravec, P Hohensinner, J Wojta, G Rega-Kaun |
Cardiovascular Diabetology | 2020 |
Reappraisal of Inflammatory Biomarkers in Heart Failure
T Chaikijurajai, WH Tang |
Current Heart Failure Reports | 2020 |
The Diabetic Cardiac Fibroblast: Mechanisms Underlying Phenotype and Function
SP Levick, A Widiapradja |
International journal of molecular sciences | 2020 |
Friend or foe of innate lymphoid cells in inflammation‐associated cardiovascular disease
X Gong, L Xia, Z Su |
Immunology | 2020 |
Galectin-3 and soluble ST2 as complementary tools to cardiac MRI for sudden cardiac death risk stratification in heart failure: A review
NN Shah, P Ayyadurai, M Saad, CE Kosmas, MU Dogar, U Patel, TJ Vittorio |
JRSM cardiovascular disease | 2020 |
The association between soluble suppression of tumorigenicity-2 and long-term prognosis in patients with coronary artery disease: A meta-analysis
N Liu, T Hang, X Gao, W Yang, W Kong, Q Lou, J Yang, V Lionetti |
PloS one | 2020 |
Biomarkers of IL-33 and sST2 and Lack of Association with Carvedilol Therapy in Heart Failure N Firouzabadi, M Dashti, A Dehshahri, E Bahramali |
Clinical pharmacology : advances and applications | 2020 |
Circulating biomarkers in the early detection of hypertensive heart disease: usefulness in the developing world
D Ojji, E Libhaber, K Lamont, F Thienemann, K Sliwa |
Cardiovascular diagnosis and therapy | 2020 |
Suppression of Tumourigenicity 2 in Heart Failure With Preserved Ejection Fraction
V Zach, FL Bähr, F Edelmann |
Cardiac Failure Review | 2020 |
Association of soluble ST2 with all-cause and cardiovascular mortality in renal transplant recipients: a single-centre cohort study
PA Devine, C Cardwell, AP Maxwell |
BMC Nephrology | 2020 |
Association of plasma-soluble ST2 and galectin-3 with cardiovascular events and mortality following cardiac surgery
DM Patel, H Thiessen-Philbrook, JR Brown, E McArthur, DG Moledina, SG Mansour, MG Shlipak, JL Koyner, P Kavsak, RP Whitlock, AD Everett, DJ Malenka, AX Garg, SG Coca, CR Parikh |
American Heart Journal | 2020 |
Innate Lymphoid Cells Play a Pathogenic Role in Pericarditis
HS Choi, T Won, X Hou, G Chen, W Bracamonte-Baran, MV Talor, I Jurčová, O Szárszoi, L Čurnova, I Stříž, JE Hooper, V Melenovský, D Čiháková |
Cell Reports | 2020 |
Nociceptor Interleukin 33 Receptor/ST2 Signaling in Vibration-Induced Muscle Pain in the Rat
P Alvarez, O Bogen, JD Levine |
The journal of pain : official journal of the American Pain Society | 2020 |
Human Immunodeficiency Virus–Associated Myocardial Diastolic Dysfunction and Soluble ST2 Concentration in Tanzanian Adults: A Cross-Sectional Study
JR Kingery, P Goyal, R Hosalli, MH Lee, B Desderius, F Kalokola, A Makubi, S Fadhil, S Kapiga, D Karmali, D Kaminstein, R Devereux, M McNairy, W Johnson, D Fitzgerald, R Peck |
The Journal of Infectious Diseases | 2020 |
Endothelin-1, cardiac morphology, and heart failure: the MESA angiogenesis study
PJ Leary, NS Jenny, DA Bluemke, SM Kawut, RA Kronmal, JA Lima, BA Maron, DD Ralph, SG Rayner, JJ Ryan, ZL Steinberg, KD Stukovsky, RJ Tedford |
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation | 2020 |
Time-dependent, dynamic prediction of fatty acid-binding protein 4, Galectin-3, and soluble ST2 measurement with poor outcome after acute stroke
C Hansen, C Sastre, Z Wolcott, MB Bevers, WT Kimberly |
International Journal of Stroke | 2020 |
Are existing and emerging biomarkers associated with cardiorespiratory fitness in patients with chronic heart failure?
M Fudim, JP Kelly, AD Jones, OF AbouEzzeddine, AP Ambrosy, SJ Greene, YN Reddy, KJ Anstrom, B Alhanti, GD Lewis, AF Hernandez, GM Felker |
American Heart Journal | 2020 |
Association of Soluble Suppression of Tumorigenesis 2 (sST2) With Platelet Activation, Monocyte Tissue Factor and Ischemic Outcomes Following Angioplasty and Stenting
S Stojkovic, S Demyanets, CW Kopp, C Hengstenberg, J Wojta, B Eichelberger, S Panzer, T Gremmel |
Frontiers in Cardiovascular Medicine | 2020 |
IL-33 and its decoy sST2 in patients with Alzheimer’s disease and mild cognitive impairment
M Saresella, I Marventano, F Piancone, FL Rosa, D Galimberti, C Fenoglio, E Scarpini, M Clerici |
Journal of Neuroinflammation | 2020 |
Correlative Study on Impaired Prostaglandin E2 Regulation in Epicardial Adipose Tissue and Its Role in Maladaptive Cardiac Remodeling via EPAC2 and ST2 Signaling in Overweight Cardiovascular Disease Subjects
E Vianello, E Dozio, F Bandera, M Froldi, E Micaglio, J Lamont, L Tacchini, G Schmitz, MM Romanelli |
International journal of molecular sciences | 2020 |
Soluble ST2 is associated with increased carotid intima-media thickness in patients with type 2 diabetes mellitus: A case-control study
X Hu, H Zhang, Y Song, Q Yang, L Zhuang, G Jin, S Zhang, W Sun, Z Shi |
Medicine | 2020 |
Combining Novel Biomarkers for Risk Stratification of Two-Year Cardiovascular Mortality in Patients with ST-Elevation Myocardial Infarction
N Zagidullin, LJ Motloch, D Gareeva, A Hamitova, I Lakman, I Krioni, D Popov, R Zulkarneev, V Paar, K Kopp, P Jirak, V Ishmetov, UC Hoppe, E Tulbaev, V Pavlov |
Journal of Clinical Medicine | 2020 |
Serum ST2 and hospitalization rates in Caucasian and African American outpatients with heart failure
P Savvoulidis, JV Snider, S Rawal, AA Morris, J Butler, VV Georgiopoulou, AP Kalogeropoulos |
International Journal of Cardiology | 2020 |
Serum soluble suppression of tumorigenicity-2 level associates with severity of pulmonary hypertension associated with uncorrected atrial septal defect
RS Pratama, AB Hartopo, DW Anggrahini, VC Dewanto, LK Dinarti |
Pulmonary circulation | 2020 |
Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and Controls
P Jirak, R Pistulli, M Lichtenauer, B Wernly, V Paar, LJ Motloch, R Rezar, C Jung, UC Hoppe, PC Schulze, D Kretzschmar, RC Braun-Dullaeus, T Bekfani |
Journal of Clinical Medicine | 2020 |
Soluble Suppression of Tumorigenicity 2 is Directly Correlated with Glycated Hemoglobin in Individuals with an Average glycemia in the Normal/Prediabetes Range A Hasan, W Al-Dhahi |
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2020 |
Cardiac Endocrinology
J Zhao, L Pei |
JACC: Basic to Translational Science | 2020 |
Soluble ST2, Galectin-3 and clinical prognosis of patients with hypertrophic cardiomyopathy undergoing ventricular septal myectomy: a correlation analysis
B Song, B Yao, H Dang, R Dong |
Cardiovascular diagnosis and therapy | 2020 |
ST2 predicts risk of unplanned readmission within one year after pediatric congenital heart surgery
Parker DM, Everett AD, Stabler ME, Jacobs ML, Jacobs JP, Vricella L, Thiessen-Philbrook H, Parikh CR, Manlhiot C, Brown JR |
The Annals of Thoracic Surgery | 2020 |
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
Abbate A, Toldo S, Marchetti C, Kron J, Van Tassell BW, Dinarello CA |
Circulation research | 2020 |